A human serum containing a monoclonal anti-(blood-group I) antibody was used to investigate the distribution of blood-group-I antigen on erythrocyte membrane components. Sodium dodecyl sulphate/polyacrylamide-gel-electrophoresis profiles of immune precipitates by using 3H-labelled (by the galactose oxidase/NaB3H4 method) and 1251_ labelled solubilized stroma were compared. Different radioactive profiles were revealed by the two radiolabelling methods. In the immunoprecipitates the predominant 125I radioactivity within the gel had the electrophoretic mobility of Band-3 protein (apparent mol.wt. 90000-100000), whereas the 3H radioactivity revealed a diffusely migrating component(s) (apparent mol.wt. range 40000-70000) in addition to radioactivity compatible with glycolipids at the dye front. The diffusely migrating 3H-labelled component was shown to have a similar electrophoretic mobility to a subpopulation of erythrocyte poly(glycosyl)ceramides with blood-group-I activity.
The blood-group-I and -i antigens are carbohydrate structures on the surface of adult and cord blood erythrocytes respectively and are defined by human autoantibodies, many of which are monoclonal immunoglobulin M proteins (Feizi, 1977) . It is now established that the majority of blood-group-i antigenic determinants are expressed on the straightchain carbohydrate sequence: Gal/Il ->4GlcNAcfl I3Galfl ->4GlcNAcfl -*3Gal- (Niemann et al., 1978) and the majority of bloodgroup-I determinants on the branched structure Gal,fB -*4GlcNAc,lI 6Galfi1 -÷4GIcNAcflI -3Gal
Galfll -4GlcNAcfil Feizi et al., 1979) . Thus the monoclonal anti-(blood-group I and i) autoantibodies are powerful reagents for detecting and isolating macromolecules carrying these two types of carbohydrate antigen. A recent affinity-chromatographic study of radioiodinated solubilized erythrocyte membranes, by using a monoclonal anti-(blood-group I) antibody column as an immunoadsorbent, revealed blood-group-I activity associated with Band-3 protein . Earlier immunoprecipitation studies with 3H-labelled erythrocyte membranes (by the galactose oxidase/NaB3H4 method) had revealed blood-group-I activity on an unidentified component(s) migrating diffusely in SDS/polyacrylamide gels in the apparent mol.wt. range 40000-70000; however, there was negligible radioactivity in the region of Band-3 protein (approximate mol.wt. 100000). In the present studies we have investigated these different observations by immunoprecipitation studies by using the same erythrocyte membranes radiolabelled with both 3H and l25l. We Serum containing a high-titre monoclonal anti-(blood-group I) antibody was from patient Step and has been described previously (Feizi & Kabat, 1972; Watanabe et al., 1979; Feizi et al., 1979) .
Human monoclonal immunoglobulin M without known antibody specificity was isolated from the serum of patient Ham with Waldenstrom macroglobulinaemia by Pevikon-block electrophoresis (Miiller-Eberhard & Kunkel, 1956 ). An antiserum was raised against this protein in rabbits and was used after absorption with washed blood-group-A, -B and -O erythrocytes.
A blood-group-I-active poly(glycosyl)ceramide preparation (subfraction 9A) (Kogcielak et al., 1976) (1951) with bovine serum albumin as a standard] and solubilized by adding Empigen BB to a final concentration of 1 % (v/v) at 0°C for 60min. Insoluble material was removed by centrifugation at 100000g at 2°C for 60min. The 3H-labelled supernatant was either used directly or after additional labelling with l25l by the chloramine-T method as described previously . 3H radioactivity was measured in a Packard Tri-Carb scintillation counter by using 6ml of scintillation fluid with the following composition: I litre of toluene containing 7.5g of 2,5-diphenyloxazole and 0.15g of 1,4-bis-(5-phenyloxazol-2-yl)-benzene plus 500ml of Triton X-100. The specific radioactivity of the 3H-labelled supernatant was 1. Crude glycoprotein fraction was prepared from erythrocyte membranes and a poly(glycosyl)ceramide-rich fraction isolated by chromatography on a DEAE-cellulose column as described by DejterJuszynski et al. (1978) . This fraction (equivalent to 1 ml of packed stroma), in 400#1 of 50mM-sodium phosphate buffer, pH 7.4, was treated with 5 units of galactose oxidase at room temperature for 18 h and then labelled with 3H by the addition of 1 mCi of NaB3H4 (10u1 of a 100mCi/ml solution in 1M-NaOH). After 4h at room temperature 1mg of NaBH4 was added and the labelled poly(glycosyl)-ceramides were recovered by gel filtration on a Sephadex G-25 column (20cmx0.7cm) equilibrated in 1 % (v/v) Empigen in 50mM-Tris/HCI, pH 8.2. The total radioactivity in this fraction was 6.5 x 106 c.p.m.
Radiolabelling of blood-group-I-active poly(glycosyl)-ceramide sub-fraction 9A
A sample (12,ug) Vol. 181 Empigen affected the precipitation. As a reference antigen, a radioiodinated blood-group-I-active glycoprotein isolated from sheep gastric mucosa was used which had been specifically enriched for blood-group-I activity by affinity chromatography on an anti-(blood-group I) antibody adsorbent (Wood et al., 1979) . The following precipitation experiments were carried out:
(a) double-antibody precipitation as described above, by using 1.4x 10'c.p. 
Polyacrylamide-gel electrophoresis
Electrophoresis was performed at 100V in 7.5% polyacrylamide (acrylamide/NN'-methylenebisacrylamide, 37:1) disc gels containing 0.1 % SDS and 0.5M-urea by the system of Laemmli (1970) . The gels were frozen at -70°C and cut into 1 mm slices with a Mickle gel slicer (Mickle Laboratory Engineering Co., Gomshall, Surrey, U.K.). Gel slices were counted directly for 1251 y-radioactivity. For counting 3H radioactivity the gel slices were first treated with 0.6ml of aq. 90% (v/v) NCS solubilizer at 50°C for 2h and then mixed with 6ml of scintillation fluid.
Results
Polyacrylamide-gel-electrophoresis patterns of radiolabelled solubilized erythrocyte membranes and the immunoprecipitates obtained with the anti-(bloodgroup-I) serum The radioactivity profile of the 3H-labelled solubilized stroma (Fig. la) was similar to that described by Gahmberg (1976) . The greatest radiowere: phosphorylase a (94000); bovine serum albumin (68000); ovalbumin (43000); trypsin (23 000); Bromophenol Blue (BPB). Fig. 1. activity (approx. 70% of that applied) was at the dye front coincident with the migration of lowmolecular-weight glycolipids. Within the gel there were three main areas of radioactivity in the apparent mol.wt. ranges 70000-110000, 30000-70000 and 17000-24000. The immunoprecipitates with the anti-(blood-group I) serum contained 11 % of the radioactivitiy of the starting material; only 0.08 ' was precipitated with normal human serum. On electrophoresis, the anti-(blood-group I) immunoprecipitate showed a broad band with a peak at an apparent mol.wt. of 44000; the highest radioactivity (approx. 90% of that applied) was again at the dye front (Fig. lb) .
The l25l y-radioactivity profile of the solubilized 3H/1251-labelled stroma (Fig. lc) showed a major peak at an approximate mol.wt. of 100000 (corresponding to Band 3), in addition to peaks at approx. 200000 (spectrin), 58000, 40000 (PAS 2) and at the dye front. The immunoprecipitate with the anti-(blood-group I) serum contained 2.1 % of the radioactivity used; with normal human serum 0.12% of the radioactivity was precipitated. The 1251 y-radioactivity profile of the anti-(blood-group I) immunoprecipitate (Fig. Id) was very different from that seen by counting for 3H (Fig. lb) . In agreement with earlier experiments , the main 'l25-labelled blood-group-I-active component was a peak in the apparent mol.wt. range 90000-100000, corresponding to Band-3 protein.
Two minor broad areas of radioactivity were observed in the apparent mol.wt. range 38000-70000 and 20000-31000. The 1251 radioactivity profile of the immunoprecipitate obtained with normal human serum (Fig. Id, dotted line) showed only negligible radioactivity in the apparent mol.wt. range 90000-100000.
Polyacrylamide-gel-ekectrophoresis profiles of 3H-labelled erythrocyte poly(glycosyl)ceramides and of their immunoprecipitates with anti-(blood-group I) serum Figs. 2(a) and 2(c) show the radioactivity profiles of the 3H-labelled poly(glycosyl)ceramide-rich fraction isolated by the method of Dejter-Juszynski et al. (1978) and the poly(glycosyl)ceramide subfraction 9A of Kogcielak et al. (1976) . In both cases a broad zone of radioactivity was observed migrating between apparent mol.wts. of 17000 and 75000. The immunoprecipitates with the anti-(blood-group I) serum contained 1.1 and 3% of the radioactivity, respectively, in the starting materials; with normal human serum 0.13 and 0.09% of the radioactivity, respectively, were precipitated. The electrophoretic patterns of the anti-(blood-group I) immunoprecipitates obtained with these two preparations (Figs. 2b and 2d) were similar. In each case, precipitating activity was confined to the slower-migrating compo-1979 nents of the original material, with a major peak at an apparent mol.wt. of 47000.
Discussion
These data show that different blood-group-I-active erythrocyte components are preferentially labelled by radioiodination or galactose oxidase/NaB3H4 treatment. The sensitivity of detection ofantigenically active components in this type of experiment depends on the degree of incorporation of the radioisotope. This is evident with Band-3 protein, which has a carbohydrate content of only 5-8 %; a higher specific radioactivity is likely to result from the incorporation of 1251 into the protein moiety rather than of 3H into a limited number of accessible galactose residues. However, with highly glycosylated molecules of the membrane such as the low-molecular-weight glycolipids and poly(glycosyl)ceramides, some of which are known to have blood-group-I activity associated with terminal galactose residues Niemann et al., 1978; Watanabe et al., 1979; Ko §cielak et al., 1976) , higher specific radioactivities and increased sensitivity of detection would be expected by the incorporation of 3H.
The bands of radioactivity in the anti-(blood-group I) immunoprecipitates of the two poly(glycosyl)-ceramide preparations indicated that only a slowly migrating subpopulation of poly(glycosyl)ceramides is precipitable with anti-(blood-group I) antibody. There was a striking similarity between these two bands (Figs. 2b and 2d ) and the diffusely migrating band observed with the immunoprecipitate of the 3H-labelled solubilized membranes (Fig. lb) , suggesting that the latter may represent a subpopulation of poly(glycosyl)ceramides. It is possible that the minor, diffuse zone of radioactivity in the apparent mol.wt. range 38000-70000 observed with the immunoprecipitate counted for 1251 radioactivity (Fig. Id) represents non-specific uptake of 1251 on to the double bonds (Welton & Aust, 1972) of the ceramide moiety of poly(glycosyl)ceramides.
Further experiments are required to investigate whether all the diffusely migrating 3H-labelled blood-group-I-active components of the stroma in the apparent mol.wt. range 40000-70000 are poly(glycosyl)ceramides, and to determine their relationship to the blood-group-I-active membrane fraction isolated by Ebert et al. (1975) and to the diffusely migrating membrane components obtained with immune precipitates by using anti-globoside and anti-paragloboside antisera (Tonegawa & Hakomori, 1977 (Feizi et al., 1971) . Therefore the bands of radioactivity in the anti-(blood-group I) immunoprecipitates (Fig. ld) are unlikely to represent PAS bands I and 2. A limitation of immunoprecipitation (as well as affinity chromatography) experiments with these anti-blood-group antibodies is their dependence on the multivalent expression of antigens. This may in part account for the low percentage of precipitable blood-group-I activity detected in Band-3 protein (Childs etal., 1978) and in the poly(glycosyl)ceramide fractions in the present studies. On the other hand, these findings are a reflection of the well-known microheterogeneity of oligosaccharide chains in glycoproteins and glycolipids. Even when glycoprotein preparations with strong blood-group-I activity are tested (before specific enrichment) in immunoprecipitation and affinity-chromatography experiments (for example, blood-group-l-active glycoprotein extracts from individual sheep gastric mucosae) only 25 % of the macromolecules were specifically precipitable by anti-(blood-group 1) antibody or retained by an anti-(blood-group I) immunoadsorbent column (Wood etal., 1979) . Nonetheless, experiments similar to those in the present studies with antisera specific for the blood-group-A, -B and-H antigenic determinants should give useful information on the still unresolved subject of the distribution of the major blood-group antigens on erythrocyte glycoproteins.
Note Added in Proof (Received 29 March 1979)
The occurrence of poly(glycosyl) chains on erythrocyte glycoproteins has been described (Krusius et al., 1978; Jarnefelt et al., 1978) ; their terminal saccharide structures resemble those of poly(glycosyl)ceramides and contain sequences now known to be associated with blood-group-I activity.
We are indebted to Dr. S. Hakomori for his helpful advice and to Dr. J. Kogcielak for providing the poly-(glycosyl)ceramide fraction 9A.
